Atorvastatin Calcium
Product Images NDC 60760-558

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 60760-558). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

558-30 (Atorvastation 60760 558 30)

558-30 (Atorvastation 60760 558 30)
This is a description of a medication named Atorvastatin, manufactured by Gravili Pharmaceuticals in India. This medication is in the form of tablets available in 40mg strength. The NDC code is 60760-558-30, and it is prescribed with RX numbers and LOT numbers. The tablets are packed by Sapy Sty in Arizona and should be stored at controlled room temperature between 15 and 30 degrees Celsius.*
FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 01)

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 02)

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 03)

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 03)
This appears to be a partial table or graph showing the cumulative hazard percentage for a placebo and Atorvastatin over a four-year follow-up period. It also notes the hazard ratio and statistical significance between the two treatments. However, without additional information or context, it is difficult to provide a more specific description or interpretation of the data.*
FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.